Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO) will sell its stake in one of its foreign investments to a US-based company listed on the New York Stock Exchange.
SPIMACO didn’t disclose the name of the concerned investment due to a confidentiality clause, adding that it expects a profit of SAR 150 million from the transaction, which will appear in second quarter financial statements.
The company’s board of directors has already approved the offer, according to its statement to Tadawul.
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}